Easywell Biomedicals, Inc. (TPEX: 1799)
Taiwan
· Delayed Price · Currency is TWD 67.60
+0.20 (0.30%)
Nov 20, 2024, 1:08 PM CST
Easywell Biomedicals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -141.46 | -144.82 | -161 | -150.39 | -173.41 | -271.8 | Upgrade
|
| Depreciation & Amortization | 70.26 | 65.13 | 66.55 | 70.78 | 80.69 | 85.71 | Upgrade
|
| Other Amortization | 0.06 | 0.02 | - | 0.1 | 0.24 | 2.28 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | - | - | -0.24 | -1.49 | -0.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 43.63 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.75 | Upgrade
|
| Stock-Based Compensation | 25.8 | 16.96 | - | - | - | -0.96 | Upgrade
|
| Other Operating Activities | -25.84 | -25.14 | -7.46 | -37.23 | -11 | 4.46 | Upgrade
|
| Change in Accounts Receivable | -18 | -47.17 | 13.08 | -5.66 | -11.08 | 68.46 | Upgrade
|
| Change in Inventory | -116.19 | -15.59 | -3.92 | 9.95 | -24.63 | -4.11 | Upgrade
|
| Change in Accounts Payable | 25.21 | 7.17 | 1.78 | 0.08 | -10.62 | -47.44 | Upgrade
|
| Change in Unearned Revenue | 8.8 | 5.7 | 20.56 | -4.08 | -8.95 | -3.78 | Upgrade
|
| Change in Other Net Operating Assets | -11.7 | -13.72 | 1.9 | 3.39 | 2.38 | -14.69 | Upgrade
|
| Operating Cash Flow | -203.04 | -151.45 | -53.5 | -128.31 | -157.87 | -171.35 | Upgrade
|
| Capital Expenditures | -17.39 | -17.73 | -7.49 | -7.71 | -16.96 | -21.72 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | - | - | 0.24 | 1.49 | 0.12 | Upgrade
|
| Divestitures | - | - | - | - | - | -14.18 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.95 | -0.82 | - | - | -0.19 | - | Upgrade
|
| Investment in Securities | -31.48 | 106.38 | 80.14 | -175.07 | -34.7 | - | Upgrade
|
| Other Investing Activities | -0.16 | -0.37 | 0.01 | - | 0 | 0.18 | Upgrade
|
| Investing Cash Flow | -49.96 | 87.46 | 72.66 | -182.54 | -50.36 | -35.61 | Upgrade
|
| Short-Term Debt Issued | - | 43.93 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 17.94 | - | Upgrade
|
| Total Debt Issued | 39.71 | 43.93 | - | - | 17.94 | - | Upgrade
|
| Long-Term Debt Repaid | - | -15.47 | -10.55 | -9.45 | -111.12 | -9.48 | Upgrade
|
| Total Debt Repaid | -59.14 | -15.47 | -10.55 | -9.45 | -111.12 | -9.48 | Upgrade
|
| Net Debt Issued (Repaid) | -19.42 | 28.46 | -10.55 | -9.45 | -93.18 | -9.48 | Upgrade
|
| Issuance of Common Stock | 186.6 | 15 | - | 329.76 | 200.48 | 244.23 | Upgrade
|
| Other Financing Activities | 134.65 | 134.39 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 301.83 | 177.84 | -10.55 | 320.31 | 107.3 | 234.75 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.92 | -9.98 | -2.61 | -1.33 | 8.55 | -0.18 | Upgrade
|
| Net Cash Flow | 46.9 | 103.88 | 6 | 8.14 | -92.38 | 27.62 | Upgrade
|
| Free Cash Flow | -220.43 | -169.17 | -60.99 | -136.02 | -174.83 | -193.07 | Upgrade
|
| Free Cash Flow Margin | -60.98% | -62.28% | -34.09% | -68.95% | -65.32% | -53.64% | Upgrade
|
| Free Cash Flow Per Share | -1.89 | -1.48 | -0.53 | -1.28 | -1.87 | -2.52 | Upgrade
|
| Cash Interest Paid | 20.01 | 19.03 | 17.25 | 16.08 | 15.65 | 16.84 | Upgrade
|
| Cash Income Tax Paid | 0.52 | 0.42 | 0.19 | 0.84 | 2.02 | 0.67 | Upgrade
|
| Levered Free Cash Flow | -153.38 | -117.85 | -28.28 | -79.6 | -52.22 | -60.71 | Upgrade
|
| Unlevered Free Cash Flow | -140.76 | -105.81 | -17.5 | -69.55 | -42.18 | -49.27 | Upgrade
|
| Change in Net Working Capital | 119.43 | 67.67 | -24.22 | 0.3 | 6.67 | -20.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.